Monocytes are short-lived mononuclear phagocytes that circulate in the bloodstream and comprise two main subpopulations that in the mouse are best defined by the Ly6C marker. Intravascular functions of "classical" Ly6C + monocytes and their interactions with other lymphoid and myeloid leukocytes in the circulation remain poorly understood. Rather, these cells are known to efficiently extravasate into tissues. Indeed, Ly6C + monocytes and their descendants have emerged as a third, highly plastic and dynamic cellular system that complements the two classical, tissue-resident mononuclear phagocyte compartments, i.e., macrophages and dendritic cells, on demand. Following recruitment to injured tissue, Ly6C + monocytes respond to local cues and can critically contribute to the initiation and resolution of inflammatory reactions. The second main murine monocyte subset, Ly6Ccells, derive in steady state from Ly6C + monocytes and remain in the vasculature, where the cells act as scavengers. Moreover, a major fraction of Ly6Cmonocytes adheres to the capillary endothelium and patrols the vessel wall for surveillance. Given the central role of monocytes in homeostasis and pathology, in-depth study of this cellular compartment can be highly informative on the health state of the organism and provides an attractive target for therapeutic intervention.
Monocytes are a conserved population of leukocytes that are present in all vertebrates, with some evidence of a parallel cell population in fly hemolymph (1) . Monocytes are defined by their location in the bloodstream, their phenotype and nuclear morphology, as well as by their characteristic gene and microRNA expression signatures (2) (3) (4) (5) . In mice, monocytes represent 4% of the nucleated cells in the blood, with considerable marginal pools in the spleen and lungs that can be mobilized on demand (6, 7) . Within the blood, monocytes, and in particular the classical Ly6C + mouse subset, exhibit a characteristically short half-life of 20 h (8), akin to that of similar ephemer neutrophils (9) .
MONOCYTE ORIGINS
Monocyte development in adult mice depends on colonystimulating factor-1 (CSF-1; also known as macrophage CSF [M-CSF]), and mice deficient for this growth factor or its receptor, CSF-1R (also known as CD115 and M-CSFR), exhibit severe monocytopenia (9) . Monocytes arise from myeloid precursor cells in primary lymphoid organs, including the fetal liver (10) and bone marrow (BM), during both embryonic and adult hematopoiesis. As opposed to adult monocytes, fetal liver monocytes were shown to proliferate and to be independent of CSF-1 (10) . However, available information on these cells is scarce, and we will focus hence in the remainder of this review on monocytes in the adult.
A major breakthrough in our understanding of monocyte biology, and the organization of the mononuclear phagocyte system as a whole, was the identification of dedicated clonotypic precursor cells, termed monocyte/macrophage dendritic cell (DC) progenitors (MDPs), in mouse BM (11) (Fig. 1 ). MDPs are defined as lineage-negative (Lin -) cells that express CD117 (also known as KIT), CD135 (also known as FLT3), and CSF-1R ( Fig. 2A ). Adoptive transfer of MDPs into BM cavities has established that these cells are bona fide monocyte precursors (12) . As opposed to granulocyte/ macrophage progenitors (GMPs), MDPs have been reported to lack the potential to generate neutrophils but are still multipotent, as they can give rise to plasmacytoid DCs (pDCs) and classical DCs (cDCs) (11) (12) (13) . MDP differentiation toward monocytes includes a defined transient intermediate, the common monocyte progenitors (cMoPs) (14) . cMoPs differ from MDPs by their lack of CD135 expression, as well as by their loss of cDC or pDC potential (14) . Adoptively transferred cMoPs have been shown to give rise to both Ly6C + and Ly6Cmonocyte subsets, albeit with distinct kinetics (14) . Of note, single-cell transcriptome profiling (15) und advanced multiparameter flow analysis (16) are likely to reveal heterogeneity within myeloid precursor populations, which might explain current controversies (17) and could result in revisions of the current hematopoietic trees.
Steady-state adult monopoiesis is restricted to the BM, and egress of monocytes from BM has emerged as a critical checkpoint controlling the abundance of blood monocytes. Specifically, the Pamer group has shown that monocyte emigration from the BM requires the chemokine receptor CCR2, whose expression is restricted to Ly6C + cells (18) . Toll-like receptor (TLR) ligands or peripheral bacterial infections rapidly induce expression of the CCR2 ligand CCL2 (monocyte chemoattractant protein-1) on BM mesenchymal cells and thereby boost CCR2-dependent monocyte egress (19, 20) . Interestingly, steady-state abundance of Ly6C + but not Ly6Cmonocytes in the circulation was reported to undergo diurnal oscillations (21) , although the exact mechanism underlying this phenomenon remains to be elucidated.
Monocyte development has to date been studied mainly in steady state. Given the ample communication circuits between the periphery and the BM, monopoiesis is, however, likely to be affected by challenges. Peripheral inflammation and stress are documented to lead to increased monocyte numbers in the circulation presumably by impacting on hematopoiesis (22, 23) . Acute elevation of "classical" monocyte numbers in the circulation, for instance, following exercise, is probably linked to the release of these cells from marginal pools (24), i.e., areas of reduced blood velocity from where the cells can be mobilized in a catecholamine-dependent fashion (25) . Interestingly, though, emerging evidence suggests that the monocyte compartment is not only affected quantitatively, but can also be qualitatively changed. Thus, monocytes have been proposed to be preemptively educated in the BM to promote their tissue-specific function at sites of persistent challenge (26) . Specifically, an intestinal Toxoplasma parasite infection was shown to lead to systemic interleukin-12 that triggered gamma interferon production by BM-resident natural killer (NK) cells, which in turn profoundly affected the gene expression profile of cMoPs and BM monocytes (26) . Similar scenarios, combined with longerlasting epigenetic alterations in monocyte precursors, may account for the reported intriguing phenomenon of "trained immunity" (27, 28) , although the underlying mechanisms remain to be defined. FIGURE 1 Schematic of murine monocyte development and monocyte fates. Ly6C + monocytes are continuously generated in the adult BM in steady state from hematopoietic stem cells (HSCs) via a sequence comprising common myeloid precursors (CMPs), GMPs, MDPs (11) , and cMoPs (14) . The BM also harbors a rare population of Ly6Cmonocytes that could derive from Ly6C + monocytes or cMoPs, but the function of this subset is unknown. Ly6C + monocytes egress to the circulation, a process that requires CCR2 (18) . Ly6C + blood monocytes have a half-life of 20 h and several potential fates: (i) differentiation into Ly6Cmonocytes that patrol the endothelial surface of the vasculature; (ii) extravasation to selected tissues whose steady-state macrophage compartment requires maintenance by monocyte recruitment, such as the intestine (6, 7); and (iii) recruitment to sites of tissue injury, infection, wounds, tumors, and inflammation, where the cells differentiate depending on local cues and give rise to cells with macrophage or DC features. Ly6C + monocytes can also return from the circulation to the BM cavities (12) , where their fate remains unclear. Of note, the scheme refers to monocyte development in steady state, while under challenge alternative developmental routes could be activated that might, for instance, bypass the MDP stage.
Given the central role of monocytes in inflammation, tissue restoration, and immunopathologies, the impact of peripheral challenges and chronic inflammation on the monocyte compartment clearly deserves further study and should profit from the recent advance in profiling techniques, including single-cell analysis (29) . Mechanisms that alter monocyte signatures could include mere acceleration of monopoiesis or the alteration of developmental routes ( Fig. 1 ), but also the activation of alternative extramedullary sites for monocyte generation, as shown for an atherosclerosis model (30) .
MONOCYTE SUBSETS
Heterogeneity within monocytes was first reported in 1989 by Ziegler-Heitbrock and colleagues for human blood (31) , and the two main human monocyte subpopulations are currently defined as CD14 + CD16and CD14 dim CD16 + cells (32) . In addition, human blood harbors an intriguing rare "intermediate" CD14 + CD16 + monocyte population, whose differential abundance in individuals could have diagnostic value (32) . Monocyte heterogeneity in mice was only defined more than a decade after its discovery in man. Specifically, flow cytometric analysis of a transgenic mouse strain that carried an insertion of a green fluorescent protein (GFP) reporter gene in the locus of the CX3CR1 chemokine receptor (CX3CR1 gfp animals) (9) had revealed discrete monocyte subpopulations that could be discriminated according to GFP reporter intensity, as well as surface markers such as the chemokine receptor CCR2 and CD62L (L-selectin) (33, 34) . The two main murine monocyte subsets, in unchallenged animals collectively defined as blood cells that express high levels of the CSF-1 receptor CD115, are currently phenotypically characterized as CX3CR1 med CCR2 + CD62L + Ly6C hi (Ly6C + ) and CX3CR1 hi CCR2 -CD62L -Ly6C lo (Ly6C -) cells (33-35) ( Fig. 2B ). Gene expression profiling and functional studies established that Ly6C + and Ly6Cmonocytes are equivalents of the human CD14 + and CD14 dim CD16 + monocyte subsets, respectively, although interesting distinctions remain (2, 4) . Of note, as in the human, mouse monocytes also comprise an additional distinct transition state (36) , which remains, however, less well characterized in terms of phenotype and function.
Animals transiently depleted of monocytes using clodronate liposomes show distinct reappearance kinetics of Ly6C + and Ly6Cmonocytes. This suggests that Ly6C + monocytes might be precursors of Ly6Ccells (37) . The identification of a putative intermediate Ly6C mid CCR7 + CCR8 + monocyte subset supported this notion (36) , which was subsequently proven directly by adoptive transfer experiment. Thus, Ly6C + monocytes isolated from BM or spleen of CX3CR1 gfp donor mice were shown to give upon intravenous transfer into wildtype recipients efficient rise to circulating Ly6Ccells (8, 12) . Moreover, following adoptive transfer of MDPs or cMoPs, graft-derived Ly6Ccells arose, as compared to Ly6C + monocytes, with a considerable delay (14) . Steady-state blood monocyte conversion was further supported by results of less invasive bromodeoxyuridine incorporation assays showing (i) that Ly6C + and Ly6Cmonocytes display sequential label acquisition and (ii) that labeling of Ly6Cmonocytes requires the presence of Ly6C + blood monocytes (8) . Interestingly, the bromodeoxyuridine assay showed similar results for the CD14 + and CD14 dim CD16 + monocyte subsets of macaques (38) , indicating that monocyte conversion is a conserved feature among rodents and primates. Of note, certain gene mutations, including the one affecting expression of CCR2, and the transcription factors (TFs) interferon regulatory factor 8 (IRF8) and Krüppel-like factor 4 (KLF4) were shown to selectively impair the generation of Ly6C + monocytes (18, (39) (40) (41) but seemingly did not affect the Ly6Ccells. This could be interpreted as evidence for the existence of a developmental pathway of Ly6Cmonocytes that is independent of Ly6C + monocytes. However, fate mapping experiments have shown that absence of Ly6C + monocytes in CCR2deficient animals results in a compensatory extension of the half-life of Ly6Ccells that could be linked to CSF-1 availability (8) . Impairment of this cellular compartment could hence also be masked in other mutant mice. Conversely, the selective absence of Ly6Cmonocytes in NR4A1-deficient animals has been interpreted as evidence for a dedicated developmental pathway of these cells (42) . However, the NR4A1 deficiency could affect the generation of these cells from Ly6Cmonocytes rather than a putative direct derivation from cMoPs. Collectively, the above studies and that of others (7) provide compelling evidence that the two main circulating murine monocyte subsets form in steady state an obligatory developmental sequence. Notably, the existence of an Ly6C + -independent route from cMoPs or other precursors to Ly6Cmonocytes, particularly in pathological settings, can currently not be excluded but awaits experimental evidence. mouse Ly6C + monocytes as equivalent of classical CD14 + human monocytes (2, 4) . Comparative transcriptome analysis of monocytes with other leukocytes, as well as tissue-resident mononuclear phagocytes, has furthermore highlighted the uniqueness of these cells (43, 44) . The distinct monocyte expression profiles also include small noncoding RNAs, or microRNAs (3, 5) , that critically shape cell identities as posttranscriptional filters (45) . Moreover, in line with the emerging notion that epigenetic signatures are imprinted by environment (46) , Ly6C + monocytes also display distinct enhancer usage (44) . Specifically, this study revealed a considerable overlap with respect to promoter activities between monocytes, neutrophils, and the seven tissue macrophages tested (82% of the total 10,806 promoters). On the other hand, monocytes shared only 27% of the total 30,976 putative revealed myeloid enhancers with neutrophils and macrophages. Consistent with the prominent expression of KLF4 by Ly6C + monocytes and earlier reports of its role as a monocyte regulator (40, 41), enhancer regions found unique to monocytes were enriched for DNA sequence motif bound by KLF4 (44) . Future detailed analysis of monocytes, including Ly6C + cells, intermediates, and Ly6Ccells, using advanced genomic approaches such as indexing-first chromatin immunoprecipitation (47) and single-cell profiling (48) are likely to aid our appreciation of monocyte heterogeneity. Furthermore, analysis of alterations of the monocyte compartment following defined challenges should allow definition of signatures associated with pathology that can be translated into the human setting.
The identity and response repertoire of monocytes are defined by hierarchical and combinatorial action of a selected set of TFs (49) . For monocytes this includes "pioneer" or "lineage-determining" TFs, such as PU1.1; cell-specific TFs, such as KLF4; and stimulus-responsive TFs, such as NF-κB (50) . TFs or TF combinations that specifically regulate monocyte development remain incompletely understood, however, and most of the candidates also show effects on other hematopoietic lineages (49) . Moreover, TFs such as IRF8, PU.1 (SFPI1), and NR4A1 (Nur77), as well as members of the NF-κB family, might also promote expansion and/or survival rather than providing only instructive cues (51) .
The establishment of the requirement of a specific TF for monocyte development will arguably require its mutagenesis, preferentially restricted to monocytes. Notably, though, monocytes, and in particular the Ly6C + subset, are due to their extreme short half-life refractory to Cre/loxP-based mutagenesis (8, 52) . In absence of suitable in vitro models that recapitulate monopoiesis, the elucidation of TF hierarchies governing monocyte development will require the establishment of novel experimental approaches. Once the regulatory elements that govern monocyte-specific gene expression are mapped in detail, this could include interference with TF binding to cell-specific enhancers. Below, we discuss selected TF deficiencies affecting monocyte development and maintenance that have emerged from the analysis of respective mouse mutants and can provide a framework for future studies. More comprehensive coverage of this topic and additional primary references can be found in recent reviews (49, 51, 53) .
As master regulator of the myeloid lineage, the ETS family TF PU.1 (SFPI1) drives expression of CSF-1R receptor, which is essential for monocyte generation. (9) . Blood cells were lysed with BD lysis buffer (#349202). Cells are gated for scatter, singlets, and Lin (Ter-119, B220, Ly6G, NK1.1, TCRγδ, CD4, CD8)-negative cells expressing CD115. This gate comprises CD135 + CD117 + MDPs and CD135 -CD117 + cMoPs and CD135 -CD117monocytes. MDPs are CD11b -Ly6C -, while cMoPs are CD11b int Ly6C + . BM monocytes are CD11b + and can be subdivided according to Ly6C expression into major Ly6C + and minor Ly6C lo-neg populations. Histogram shows CX3CR1-GFP reporter gene expression of MDPs, cMoPs, and monocytes, as compared to wild-type (WT) BM (gray). Note upregulation of reporter in Ly6C int-neg BM monocytes. (B) Analysis of blood monocyte compartment of C57BL/6 and CX3CR1 gfp C57BL/6 mouse (9) . Blood cells were lysed with BD lysis buffer (#349202). Cells are gated for scatter (excluding sideward scatted [SSC] high neutrophils), singlets, and lineage negative according to Lin marker expression (B220, CD19, CD3, CD4, CD8, Ly6G, NK1.1, TCRγδ). Lincells comprise largely CD115 + CD11b + monocytes. "Ly6C + monocytes" (red) can be defined as Ly6C + CD11c -CCR2 + CD62L + CX3CR1 int and "Ly6Cmonocytes" (green) can be defined as Ly6C -CD11c int CCR2 -CD62L -CX3CR1 hi cells. Note that "Ly6C int monocytes" (blue) also show intermediate expression of the other markers, as seen in the respective histograms. This supports the notion that these cells are a transitional population. FSC, forward scatter.
Expression of low levels of PU.1 in GMPs induces granulopoiesis, whereas high PU.1 levels induce monopoiesis and expression of monocyte-associated TFs, including IRF8. IRF8-deficient mice lack Ly6C + monocytes and have reduced numbers of Ly6Cmonocytes (39) . Interestingly, IRF8 was shown to drive expression of KLF4, previously shown to be critical for the generation of Ly6C + monocytes (40, 41). The only TF so far reported to be selectively required for the generation/ survival of Ly6Cmonocytes is the orphan nuclear receptor NR4A1 (Nur77) (42) . Interestingly, NR4A1 is induced during the conversion of Ly6C + monocytes to Ly6Ccells (A. Mildner et al., in preparation). Moreover, NR4A1 is also expressed by tissue macrophages and was reported to be required for their polarization toward proinflammatory phenotypes (54) but also activities that curb inflammation (55) . The above TFs are critical for monocyte homeostasis; of equal interest, but even less well understood, are factors governing discrete in vivo responses of monocyte subsets. The microRNA miR-146a, which is highly expressed in both mouse Ly6C + and human CD14 + monocytes but not the Ly6Cand CD14 dim CD16 + subset, was for instance reported to specifically control the response of Ly6C + monocytes during inflammation by directly targeting the noncanonical NF-κB/Rel family member Relb (3).
MONOCYTE FATES AND FUNCTIONS
Monocytes were long believed to constitute merely a transient precursor reservoir for tissue-resident mononuclear phagocytes. Classical labeling experiments with [ 3 H]thymidine by van Furth and Cohn that aimed at defining the kinetics of monocyte transit in the bloodstream revealed that these cells spend at most a few days in the circulation and are then mobilized to various tissues, including the inflamed peritoneum (56) . Likewise, monocytes give efficient rise to macrophages and DC-like cells under conditions of inflammation, tissue injury, and infection (57) (58) (59) (60) . The notion that monocytes act mainly as precursors was further supported by the relative ease with which these cells can be differentiated into cells with macrophage or DC features in cultures driven by CSF-1 (M-CSF) and CSF-2 (granulocyte-macrophage CSF), respectively (61, 62) ; the validity of such culture-derived cells to serve as proxies for bona fide cells isolated from tissue has, however, recently been challenged and the cultures might be more complex than originally assumed (63) (64) (65) . Rather, it is now firmly established that classical FLT3 liganddependent migratory DCs (cDCs) that harbor a char-acteristic and unique potential to stimulate naive T cells derive from dedicated BM precursors originating from MDPs but are independent of cMoPs or monocytes (66, 67) ( Fig. 1) . Conversely, many early studies had suggested that tissue macrophages, as diverse as liver Kupffer cells, microglia, as well as splenic and lung macrophages, are largely maintained through local proliferation (for primary references, please see reference 68). More-recent fate mapping experiments involving Cre transgenic mice and inducible reporter alleles have corroborated this notion. Furthermore, they revealed that most tissue-resident macrophage compartments are established prenatally and develop locally, alongside their respective host tissue and independent from each other (8, (69) (70) (71) (72) . Maintenance of these macrophages relies on their longevity and self-renewal and is independent of ongoing hematopoiesis (73) .
Interestingly, though, specific tissues, including the gut, the skin, and the heart, show a replacement of embryonic macrophages by adult monocyte-derived cells that can either be quantitative close to birth (74, 75) or progress with time (74) (75) (76) (77) . The reason why monocytederived cells in these selected tissues can seed "tissue macrophage niches" that are otherwise restricted and how monocyte-derived cells can efficiently compete with the original embryonic populations remains unknown (78) . Given the current examples, it could be linked to unique homeostatic challenges of these organs, such as microbiota exposure in gut and skin or continuous microtrauma induced by contraction in the heart. In fact, monocyte-derived cells among tissue macrophages can also be remnants of acute monocyte infiltrates associated with past challenges, as shown, for instance, following sterile peritonitis (8) . In particular, the peritoneum seems to accumulate monocyte-derived cells alongside the embryonic-derived cells with time, although the extent of this phenomenon can vary among mouse strains (8, 79) and with gender (80) . Together with the observation that monocyte-derived cells can permanently replace embryonic macrophage populations in lung and liver when the latter are compromised by a CSF-1R deficiency or experimentally ablated (81, 82) , this establishes that monocytes can give rise to persisting tissue macrophages. Of note, gene expression profiling suggests so far that with time the monocyte-derived cells become virtually indistinguishable from the original populations (82, 83). However, the cells could differ on the epigenome level, including the abundance of "poised" enhancer loci (46) , which could encode distinct response patterns to stimulation. It thus remains to be shown whether the cells are functionally identical.
Inflammation is a crucial component of the host defense against injury and infection. Prolonged and chronic inflammatory responses, however, are detrimental for the host and can cause considerable collateral damage (84) . Accordingly, mechanisms have evolved that actively promote the resolution of inflammatory reaction and thereby efficiently prevent immunopathology (85) . Tissue infiltration of Ly6C + monocytes is central to this regulatory circuit and a hallmark of sterile and infectious inflammation. With their striking plasticity, monocytes can contribute pro-or anti-inflammatory activities, depending on the context and time of their arrival at the site of injury (60) . However, unless the original macrophage population is severely compromised (86) , monocyte-derived cells disappear once the steady state is restored. This scenario has probably been best demonstrated in the murine model for multiple sclerosis, experimental autoimmune encephalomyelitis (EAE). In this paradigm, monocytes breach the compromised blood-brain barrier of the central nervous system and actively promote pathology (87) (88) (89) . However, once acute inflammation is resolved, monocyte-derived cells disappear and the central nervous system macrophage compartment is restored to exclusively comprise yolk sac-derived microglia (89) .
Given space limitations, we refer the interested reader for a comprehensive overview of the monocyte contributions to various pathologies, such as rheumatoid arthritis, colitis, atherosclerosis, and bacterial infections, to recent excellent reviews on the topic (20, 59) . Another particularly intensely studied field is tumor settings where Ly6C + monocyte-derived tumor-associated macrophages (TAMs) can been discriminated from tissueresident macrophages. In a mammary tumor model, for instance, it was shown that TAM development from Ly6C + monocytes required Notch signaling and ablation of monocyte-derived TAMs suppressed tumor growth (90) . Monocyte-derived cells have been linked to myeloid suppressor activity; however, differential contributions of the different macrophages to cancer development clearly remain to be further defined (91) . Highlighting the central role of Ly6C + monocytes in diseases, monocyte-targeted strategies have been shown to bear considerable therapeutic potential. Thus, acute ablation of Ly6C + monocytes from the circulation using an anti-CCR2 antibody regimen was shown to ameliorate experimentally induced colitis, arthritis, and neuroinflammation (88, 92, 93) . Moreover, therapeutic CCR2 silencing in monocytes using short interfering RNA attenuated multiple pathologies, including infarct size after coronary artery occlusion and tumor progression (94) . Finally, Ly6C + monocytes have recently been successfully redirected from the circulation to the spleen for clearance using negatively charged microparticles, and this monocyte neutralization reduced disease symptoms and promoted tissue repair in a number of tested disease models (95) .
Of note, a recent study also reported on extravasated monocytes in noninflamed tissues that retain much of their monocytic character rather than differentiating to macrophages or DCs (35) . However, these cells are short-lived and could be intermediates; hence their specific contribution remains to be further elucidated.
Sites of injury often harbor monocyte-derived cells that can be divided according to Ly6C expression. This was originally interpreted as evidence that both Ly6C + and Ly6Cmonocytes extravasate and might even contribute distinct pro-and anti-inflammatory activities (96). Alternatively, Ly6C + monocytes could have lost Ly6C expression along with their differentiation into tissue cells (97), akin to their conversion into Ly6Cmonocytes. Indeed, it is now generally accepted that monocytic tissue infiltrates comprise predominantly, if not exclusively, Ly6C + monocytes, or in humans the "classical" CD14 + monocyte subset (98) . These infiltrating cells are prominently equipped with chemokine receptors allowing recruitment, including CCR2 (20) . As opposed to "classical" Ly6C + monocytes, Ly6Cmonocytes lack potential to give rise to tissue-resident cells, such as intestinal macrophages (6), but their activities seem restricted to the vascular lumen.
Seminal work by the Geissmann group has shown that a fraction of the Ly6Cmonocytes continuously patrol the vasculature of healthy tissues through lymphocyte function-associated antigen/intercellular adhesion molecule-dependent long-range crawling on the resting endothelium (99, 100) . Likewise, human CD14 dim CD16 + monocytes also showed patrolling activity when adoptively transferred into immunodeficient mice (2) . Ly6Cmonocytes display, with 2 days, a longer half-life than Ly6C + monocytes (8) . Depending on the availability of CSF-1, which has, together with the alternative CSF-1R ligand interleukin-34 (101, 102) , emerged as a critical factor controlling monocyte/macrophage maintenance (103, 104) , the half-life of Ly6Cmonocytes can moreover even be extended to almost 2 weeks (8) . In further support of their macrophage identity, Ly6Cmonocytes efficiently scavenge luminal microparticles in steady state (100) and were also reported to be critical for the removal of luminal vascular β-amyloid in a murine Alzheimer's disease model (105) .
Another key role of Ly6Cmonocytes might be their surveillance of endothelial integrity. Following exposure to TLR7-mediated "danger" signals, endothelium was thus shown to induce the retention of Ly6Cmonocytes. Simultaneously, the TLR7 ligand triggered monocytes to locally recruit neutrophils, which mediated focal endothelial necrosis, and the Ly6Cmonocytes removed the cellular debris (100) . Animals that display reduced numbers of patrolling Ly6Cmonocytes due to a missing CX3CR1 survival signal (106) or lack the cells altogether, such as NR4A1 -/mice (42), have not been reported to display spontaneous vascular abnormalities. However, they likely will be instrumental in deciphering additional physiological roles of these cells. Indeed, NR4A1 -/mice were shown to display increased lung metastasis in a tumor model, and transfer of wild-type Ly6Cmonocytes prevented tumor invasion of the lung (107) . In this model, patrolling monocytes interacted with metastasizing tumor cells, scavenged tumor material from the lung vasculature, and promoted NK-cell recruitment and activation (107) .
In-depth understanding of Ly6Cmonocytes clearly requires further investigation with intravital approaches. Their activities will likely be related to their prevalence in capillaries (100) and strategic positioning on the blood vessel wall. Ly6Cmonocytes thus highlight monocyte functions related to their specific location within the blood circulation. Intravascular functions of Ly6C + monocytes, on the other hand, and interactions of the two monocyte subsets with other lymphoid and myeloid leukocytes remain poorly understood.
CONCLUDING REMARKS
Monocytes are defined mainly by their location in the bloodstream, and full appreciation of these fascinating cells will require understanding of their activities in this special compartment, including communication with other leukocytes and the vessel wall. In addition, Ly6C + monocytes and their descendants have emerged as a third, highly plastic and dynamic cellular system that complements the two classical, tissue-resident mononuclear phagocyte compartments, i.e., macrophages and DCs, on demand. Given the central role of monocytes in homeostasis and pathology, multiparameter flow analysis and genomic profiling of these cells and their discrete subsets in human blood samples should be highly informative on the health state of individuals. Moreover, promising results from preclinical disease models suggest that monocytes represent attractive targets for therapeutic intervention for pathologies associated with acute and chronic inflammation.
